Description: Beijing Sun-Novo Pharmaceutical Research Co., Ltd., a contract research company, engages in the research and development of chemical drugs and peptide drugs in China. The company offers small molecule chemical generic drugs; peptide products; and drugs for indications, such as impetigo, acne, renal anemia, chronic kidney disease dialysis patient hyper parathyroid hormone, analgesia, and other symptoms. It also provides packaging material compatibility test, impurity research, extract research, migration research, safety evaluation, and other research services; consistency evaluation services; clinical research services; registration consulting and agency services; and range of pharmacokinetics-pharmacodynamics and GLP bioanalysis services, including pharmacokinetic bioanalysis, immunogenic biology analysis, pharmacodynamics, and biomarker bioanalysis services. The company was founded in 2009 and is based in Beijing, China.
Home Page: www.sun-novo.com
Building 7
Beijing,
102200
China
Phone:
86 10 6074 8199
Officers
| Name | Title |
|---|---|
| Mr. Yujing Liu | GM & Director |
| Mr. Lingyang Zhao | CFO, Board Sec. & Director |
| Ms. Yan Shao | Deputy Gen. Mang. |
| Mr. Xinquan Tuo | Deputy Gen. Mang. |
| Mr. Guangtao Hao | Deputy GM & Core Technician |
| Mr. Huan Luo | Deputy GM & Core Technician |
| Ms. Wang Mingjuan | Core Technical Staff |
| Mr. Xie Daosheng | Core Technical Staff |
| Mr. Yuanbo Li | Core Technical Staff |
| Mr. Gao Jian | Core Technical Staff |
Exchange: SHG
Country: CN
Currency: Renminbi (¥)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 63.5385 |
| Price-to-Book MRQ: | 9.1531 |
| Price-to-Sales TTM: | 11.9162 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 873 |